c d box coding dna fragment (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
99
Structured Review
Thermo Fisher
c d box coding dna fragment
C D Box Coding Dna Fragment, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+code/DNA/pm40763580-63-1-61
Average 99 stars, based on 1 article reviews
C D Box Coding Dna Fragment, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+code/DNA/pm40763580-63-1-61
Average 99 stars, based on 1 article reviews
c d box coding dna fragment - by Bioz Stars,
2026-11
99/100 stars
Images
Related Articles
Concentration Assay:Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis. Article Snippet: Immuno dot-blot Immuno-dot blot analysis was performed to validate the specificity of the Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis Article Snippet: Primary antibodies used: SMYD3 (12859, Cell Signaling Technology, 1:100 dilution), CD44 (3570, Cell Signaling Technology, 1:200 dilution), and Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis Article Snippet: Immuno-dot blot analysis was performed to validate the specificity of the Article Title: Methods for expansion of natural killer (NK) cell subset and related compositions and methods Article Snippet: Exemplary reagents are commercially available SNP Assays, e.g. Incubation:Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis. Article Snippet: Immuno dot-blot Immuno-dot blot analysis was performed to validate the specificity of the Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis Article Snippet: Primary antibodies used: SMYD3 (12859, Cell Signaling Technology, 1:100 dilution), CD44 (3570, Cell Signaling Technology, 1:200 dilution), and Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis Article Snippet: Immuno-dot blot analysis was performed to validate the specificity of the Article Title: Methods for expansion of natural killer (NK) cell subset and related compositions and methods Article Snippet: Exemplary reagents are commercially available SNP Assays, e.g. Affinity Purification:Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis. Article Snippet: Immuno dot-blot Immuno-dot blot analysis was performed to validate the specificity of the Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis Article Snippet: Primary antibodies used: SMYD3 (12859, Cell Signaling Technology, 1:100 dilution), CD44 (3570, Cell Signaling Technology, 1:200 dilution), and Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis Article Snippet: Immuno-dot blot analysis was performed to validate the specificity of the Article Title: Methods for expansion of natural killer (NK) cell subset and related compositions and methods Article Snippet: Exemplary reagents are commercially available SNP Assays, e.g. Membrane:Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis. Article Snippet: Immuno dot-blot Immuno-dot blot analysis was performed to validate the specificity of the Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis Article Snippet: Primary antibodies used: SMYD3 (12859, Cell Signaling Technology, 1:100 dilution), CD44 (3570, Cell Signaling Technology, 1:200 dilution), and Article Title: Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis Article Snippet: Immuno-dot blot analysis was performed to validate the specificity of the Article Title: Methods for expansion of natural killer (NK) cell subset and related compositions and methods Article Snippet: Exemplary reagents are commercially available SNP Assays, e.g. |
